T1	Intervention 782 849	placebo, 200 mg, 400 mg, 600 mg and 800 mg of ebrotidine once daily
T2	Intervention 851 1069	Controls were performed at baseline and every two weeks at four follow-up visits unless ulcer healed before. Endoscopic examination was the main parameter for the assessment of treatment efficacy and ulcer healing rate
